Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis
Clinical trial NCT04971980 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04971980
- Sponsor
- Beijing Baylx Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-12
- Primary completion
- 2023-07-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.